We are proud to share the NIIMBL technology roadmaps with the biopharmaceutical manufacturing community. These documents identify the manufacturing needs and propose a vision of the future for three key topics areas: Vaccines, Antibody-Drug Conjugates and Bi-specific Antibodies, and Gene Therapies.
The Institute convened subject matter experts from industry, academic institutions, non-profits, and federal agencies to survey the current landscape and identify areas of opportunity for each of these product classes. The diversity of stakeholders ensured these roadmaps represented a wide-range of perspective from across the ecosystem. In addition to technology experts, the process also included participants focused on workforce development and regulatory considerations. The process was facilitated by the BioPhorum Operations Group.
Read more...